United States

Who we are

  • January 1, 1970
    A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors
  • January 1, 1970
    A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
  • January 1, 1970
    Isunakinra Alone and in Combination with Pembrolizumab in Patients with Colorectal Cancer (MSS)